• BX Home
  • King Pharmaceuticals (KG): News [Page 4]

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

KING PHARMACEUTICALS (KG)

King Pharmaceuticals, Inc. is the world’s 39th-largest pharmaceutical company. It provides branded prescription pharmaceutical products worldwide It primarily offers branded prescription products for primary care physicians, neurologists, orthopedic surgeons, hospitals, internal medicine physicians, allergists, pediatricians, and pain specialists. Some brands include Altace for heart attack prevention; Levoxyl for hypothyroidism; Sonata for sleeping; and Skelaxin, a muscle relaxant.

King Pharmaceuticals (KG) is part of Business Exchange, suggested by Ginny Moore. This topic contains 133 news and 95 blog items. Read updated news, blogs, and resources about King Pharmaceuticals (KG). Find user-submitted articles and reactions on King Pharmaceuticals (KG) from like-minded professionals.

News

Please add new articles to this topic

Acura, King cite positive study on pain drugmore

10 cents, or 2.1 percent, to close at $4.91 during the regular trading session. Shares of King Pharmaceuticals, based...

UPDATE 3-King Pharmaceuticals reviews animal health unitmore

business * Shares down 1.9 percent (Recasts, adds stock price) BOSTON, Jan 15 (Reuters) - Specialty drugmaker King...

King Pharmaceuticals To Present At J.P. Morgan Healthcare Conferencemore

Extract not available.

Where Credit Is Improvingmore

Merck, Baxter International and Thermo Fisher Scientific. It has the same number of companies with negative outlooks.

UPDATE 1-Zymogenetics says court denies King Pharma motionmore

percent Dec 10 (Reuters) - ZymoGenetics Inc (ZGEN.O) said a U.S. district court denied all of King Pharmaceuticals...

US FDA seeks plan to curb opioid pain killer abusemore

and Drug Administration in February had asked manufacturers including Johnson & Johnson (JNJ.N: Quote, Profile,...

Drugmakers, FDA move to curb painkiller abusemore

prescription painkillers, under pressure from regulators trying to prevent hundreds of fatal overdoses each year.

Which Drug Companies Could Be Private-Equity Targets?more

in debt as of the quarter ended Sept. 30 and has a market cap of $2.6 billion. King Pharmaceuticals sells generic drugs...

Research and Markets: Managed Markets Account Management: Assessing th...more

Pharmaceuticals * EMD Serono * AstraZeneca * Honeywell * Bayer Schering AG * IDS * Boehringer Ingelheim * King...

ZymoGenetics injunction liftedmore

Seattle-based biotechnology company said Friday. The three restraining orders resulted from a lawsuit filed by rival...

King Pharmaceuticals to Present at Credit Suisse Healthcare Conferencemore

Extract not available.

A Conversation With King Pharma CEO Brian Markisonmore

Lee BrodieWeb ProducerDrug developer King Pharmaceuticals KGloading...� � �

King 3Q profit falls on charges, but tops forecastmore

deal. Its Meridian unit gained 6 percent to $72 million. Royalty revenue fell to $12 million. Shares of King...

King, Acura say FDA does not need new Acurox trialmore

NEW YORK - King Pharmaceuticals Inc. and Acura Pharmaceuticals Inc. said Friday they don't expect to have to run new...

Symphogen Appoints Adriann Sax Chief Business Officermore

programs.' Before Symphogen, Adriann most recently served as Executive Vice President, Corporate Strategy, Strategic...

King Pharma Gets FDA OK For Chronic-Pain Treatment Embedamore

DOW JONES NEWSWIRES King Pharmaceuticals Inc.(KG) said the U.S. Food and Drug Administration approved Embeda, a...

FDA Questions Data On Proposed Heart Imaging Drug Corvuemore

Dow Jones)- The Food and Drug Administration questioned clinical data involving Corvue, a proposed imaging drug from...

PERRY GETS WRIST SLAP IN MERGERmore

in companies over which they have voting power. Perry's stake in Mylan followed a proposed merger with King...

Perry Corp. to Pay $150,000 in S.E.C. Settlementmore

argued that it wasn’t required to immediately disclose the stake in Mylan, which was trying to buy King Pharmaceuticals...

Mylan Receives FDA Approval for Generic Version of Thyroid Deficiency ...more

5 mcg (base), 25 mcg (base) and 50 mcg (base). Liothyronine Sodium Tablets are the generic version of King...

RAPP Announces New SVP, Brand Experience Director Norbert Fruteau De L...more

Pill' sales by over 50%. In 2007, a Super Bowl TV spot for the American Heart Association and King Pharmaceuticals led...

UPDATE 1-King, Pain Therapeutics may refile Remoxy in 2010more

comes after FDA meeting * Remoxy pain drug designed to thwart abuse NEW YORK, July 7 (Reuters) - King Pharmaceuticals...

REMOXY(R) NDA Updatemore

CUPERTINO, Calif., July 7 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX) today reported that King...

Acura, King get FDA response on Acuroxmore

NEW YORK (MarketWatch) -- King Pharmaceuticals Inc. (KG) said Thursday that it and Acura Pharmaceuticals Inc.

Stocks Tumble on Jobs Newsmore

its 2009 outlook to original range it provided entering the year of $690-$720 million. Acura Pharmaceuticals (ACUR) and...

Top Sources: King Pharmaceuticals (KG)

  • Reuters
  • MarketWatch
  • TheStreet.com
  • CNBC
  • Morningstar.com
  • Wall Street Journal Online
  • BusinessWeek
  • Smart Money
  • Motley Fool
  • Reuters UK

Most Active Users in this Topic

No user contributions

Featured White Papers

Post a Job

Jobs in this Topic

Part Time Base Manager-Mayport/Kings Bay Eurpac Service | Mayport, FL
Posted: May 19
Full Time Dispensing Pharmacist in King of Prussia 6pm - 2:30am Omnicare | King of Prussia, PA
Posted: Jun 8
Hospice Medical Director with Evercare based in King of Prussia UnitedHealth Group | Pennsylvania
Posted: Jun 17
Validation Engineer - Biopharm - King of Prussia (2 028524 336492) Adecco | King of Prussia, PA
Posted: May 21
Account Executive (Seattle - South King County / Snohomish) Livingsocial | Seattle, WA
Posted: May 20

Report comment contains invalid characters. ()
cancel
Search Cancel